Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 3.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.59 | 1.85 |
NAV | ₹109.40 | ₹26.87 |
Fund Started | 11 Nov 2013 | 02 Dec 2020 |
Fund Size | ₹26379.20 Cr | ₹4844.38 Cr |
Exit Load | Exit load of 1% for investments beyond 10% if redeemed within 12 months | Exit load of 1% if redeemed within one year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.65% | 6.30% |
3 Year | 24.02% | 23.49% |
5 Year | 30.84% | - |
1 Year
3 Year
5 Year
Equity | 91.43% | 95.42% |
Cash | -1.88% | 4.56% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Cholamandalam Financial Holdings Ltd. | 2.88% |
Nifty 50 | 2.82% |
Krishna Institute of Medical Sciences Ltd | 2.75% |
Brigade Enterprises Ltd. | 2.59% |
Multi Commodity Exchange Of India Ltd. | 2.25% |
CCL Products (India) Ltd. | 2.24% |
Narayana Hrudayalaya Ltd. | 2.07% |
Blue Star Ltd. | 1.95% |
Kaynes Technology India Ltd. | 1.88% |
PB Fintech Ltd. | 1.65% |
Name | Assets |
---|---|
Multi Commodity Exchange Of India Ltd. | 3.74% |
City Union Bank Ltd. | 2.37% |
Karur Vysya Bank Ltd. | 2.29% |
Techno Electric & Engineering Company Ltd. | 2.26% |
Navin Fluorine International Ltd. | 2.00% |
Aster DM Healthcare Ltd. | 1.99% |
Affle 3I Ltd. | 1.94% |
Eris Lifesciences Ltd. | 1.87% |
Paradeep Phosphates Ltd. | 1.80% |
Kei Industries Ltd. | 1.78% |
Name | Mayank Hyanki | Nitin Jain |
Start Date | 05 Apr 2024 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity & equity related instruments of small cap companies. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of small cap companies. |
Launch Date | 11 Nov 2013 | 02 Dec 2020 |
Description
Launch Date